Arete Wealth Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,012
Closed -$409K 714
2025
Q3
$409K Buy
2,012
+13
+0.7% +$2.31K 0.03% 506
2025
Q2
$352K Sell
1,999
-72
-3% -$10.8K 0.03% 516
2025
Q1
$279K Sell
2,071
-94
-4% -$12.4K 0.02% 563
2024
Q4
$272K Sell
2,165
-43
-2% -$6.39K 0.02% 594
2024
Q3
$363K Buy
+2,208
New +$334K 0.03% 470
2022
Q2
Sell
-2,413
Closed -$207K 560
2022
Q1
$207K Buy
+2,413
New +$198K 0.02% 474

Other funds holding THC

Arete Wealth Advisors's THC Position: Q4 2025 in Review

Arete Wealth Advisors sold out of Tenet Healthcare (THC) in Q4 2025, closing a stake of 2,012 shares — an estimated $409K sold.

Arete Wealth Advisors first reported a position in THC in Q1 2022 and held it in 6 quarters. The position peaked at $409K in Q3 2025. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

  • Arete Wealth Advisors reported no remaining Tenet Healthcare position as of Q4 2025 after selling out during the quarter.
  • Arete Wealth Advisors sold 2,012 Tenet Healthcare shares in Q4 2025, an estimated $409K.
  • Arete Wealth Advisors first reported a position in Tenet Healthcare in Q1 2022 and held it in 6 quarters.
  • Arete Wealth Advisors's Tenet Healthcare position peaked at $409K in Q3 2025.
  • 705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on Arete Wealth Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.